Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?
- 1 April 2007
- journal article
- review article
- Published by Springer Nature in Nature Immunology
- Vol. 8 (4) , 329-331
- https://doi.org/10.1038/ni0407-329
Abstract
Most people infected with human immunodeficiency virus 2 (HIV-2) do not progress to disease, even though the minority who do cannot be distinguished clinically from HIV-1-infected patients. Here we review what is known about the basis of viral control in HIV-2 infection.Keywords
This publication has 29 references indexed in Scilit:
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006
- Natural Killer Cell Function Is Well Preserved in Asymptomatic Human Immunodeficiency Virus Type 2 (HIV-2) Infection but Similar to That of HIV-1 Infection When CD4 T-Cell Counts FallJournal of Virology, 2006
- Differential Restriction of Human Immunodeficiency Virus Type 2 and Simian Immunodeficiency Virus SIVmac by TRIM5α AllelesJournal of Virology, 2005
- Immunological Predictors of Survival in HIV Type 2-Infected Rural Villagers in Guinea-BissauAIDS Research and Human Retroviruses, 2005
- CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV‐2) and type 1 (HIV‐1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotypeEuropean Journal of Immunology, 2005
- Functional Analysis of Vif Protein Shows Less Restriction of Human Immunodeficiency Virus Type 2 by APOBEC3GJournal of Virology, 2005
- Comparison of Human Immunodeficiency Virus (HIV)-Specific T-Cell Responses in HIV-1- and HIV-2-Infected Individuals in SenegalJournal of Virology, 2004
- No Differences in Cellular Immune Responses between Asymptomatic HIV Type 1– and Type 2–Infected Gambian PatientsThe Journal of Infectious Diseases, 2004
- Mortality before and after HIV infection in the complete UK population of haemophiliacsNature, 1995
- HIV-2 antisera cross-neutralize HIV-1AIDS, 1988